Pathologists Lancet Kenya rebrands to Cerba Lancet Kenya during its 15th anniversary.
The diagnostic providers in Kenya announced the completion of its rebrand process on Friday.
Cerba Lancet Kenya Group CEO, Mwende Musunga noted that the name change reinforces its long-term commitment to providing better patient care.
"While the name changes, our guiding principles and business fundamentals remain unchanged. We believe that with a new look, we shall stimulate our efforts in providing enhanced diagnostic capabilities and advancing healthcare technologies to improve patient outcomes,” Mwende said.
“This is a culmination of efforts on brand transformation that we began in 2023."
Mwende also noted that the rebrand will help foster collaboration and broaden its reach to support a wider spectrum of patient needs.
"It is also expected to help position it in providing better services to our customers and support its efforts to seamlessly harness the strengths of various partners to offer world-class personalised care," Cebra Lancet CEO added.
"It is also a promise to be at the forefront of medical advancements as well as a commitment to Cerba Lancet Kenya’s ambition to maintain its leadership position in the provision of world-class private diagnostics services in Kenya."
The company aims at leveraging its Cerba Lancet Africa footprint across 14 countries as well as extensive expertise present in several certified sites with extra support from partner hospitals.
The company began its Kenyan branch in 2009 and offers diagnostic, monitoring, and screening procedures through independent laboratory facilities.
It also has a collaboration with other institutions and organisations, ranging from widely known to specialised and unique complex tests.
